bpc-157 fda status warning 2025 december and the Difference Between an Evidence Gap and a Cover 7 peptides under FDA review: – fda warning bpc 157 2025 – bpc-157 fda status warning This

Role: Skin and scalp conditioning agent

Not for human consumption or therapeutic use

Epithalon is not a drug, supplement, or food product, and is not for human consumption, veterinary use, or medical applications

Results showed 55.8% reduction in wrinkle volume compared to control serum and 32.8% reduction in wrinkle depth

FDA Advisory Committee Recommends Adding BPC-157 to Compounding List A closely watched FDA advisory committee has voted to recommend adding BPC-157 to the list of bulk drug substances that may be used by traditional compounding pharmacies, marking a potentially significant development for providers who have followed growing interest in peptide therapies

Several reported effects, including stress-axis modulation, produced positive results in animals but negative results in humans (PMID 7777652)